In a new wrinkle in Sun Pharmaceutical's plans for merging Ranbaxy Laboratories, the Indian company is putting together a list of plants that it will sell or close and among them is a facility in Tipperary, Ireland. The 100 workers there were called into a meeting and told the fate of the facility should be determined by early next year. A spokesman for the company said on Wednesday that "decisions are being made to either close or divest some of its manufacturing facilities. Currently, the Ireland facility has been identified for divestment." Story | More